Expressing support for the designation of June 1, 2026, through June 7, 2026, as "Hidradenitis Suppurativa Awareness Week".

Debbie Dingell

Democrat · MI · Representative

Source: Congress.gov · FEC

• John Joyce (R-PA-13)Original· 2026-06-02

Referred to the House Committee on Energy and Commerce.

2026-06-02

Source: Congress.gov

This resolution would officially recognize the week of June 1-7, 2026, as "Hidradenitis Suppurativa Awareness Week" to help increase public understanding of a painful chronic skin condition that affects thousands of Americans. The designation aims to encourage people to learn about the disease, which causes painful lumps and infections, and to support those living with it. This is a symbolic measure that doesn't create new laws or funding, but rather expresses Congress's support for raising awareness about the condition.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H. Res. 1331 Introduced in House (IH)] <DOC> 119th CONGRESS 2d Session H. RES. 1331 Expressing support for the designation of June 1, 2026, through June 7, 2026, as ``Hidradenitis Suppurativa Awareness Week''. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES June 2, 2026 Mrs. Dingell (for herself and Mr. Joyce of Pennsylvania) submitted the following resolution; which was referred to the Committee on Energy and Commerce _______________________________________________________________________ RESOLUTION Expressing support for the designation of June 1, 2026, through June 7, 2026, as ``Hidradenitis Suppurativa Awareness Week''. Whereas Hidradenitis Suppurativa (in this resolution referred to as ``HS'') is a chronic, inflammatory skin disease that affects approximately 3,300,000 people in the United States; Whereas HS causes painful, boil-like nodules and abscesses anywhere on the body, and can progress to form tunnels under the skin and cause extensive scarring; Whereas individuals with HS frequently suffer from 5 primary domains of physical and emotional suffering, pain, drainage, odor, itching, and profound psychological distress; Whereas HS is associated with one of the highest completed suicide rates among dermatological diseases, second only to melanoma; Whereas 75 percent of individuals with HS are misdiagnosed or not diagnosed until after age 25, missing critical windows for early intervention and care; Whereas delayed diagnosis contributes to worsening disease progression, higher healthcare costs, avoidable emergency room visits, and unnecessary procedures; Whereas individuals are often diagnosed with HS in the prime of their lives, affecting their ability to work, maintain relationships, and participate fully in society; Whereas there are currently only 3 biologic therapies approved by the Food and Drug Administration for the treatment of HS; Whereas additional research is urgently needed to develop new treatments, understand the pathogenesis of the disease, identify biomarkers of HS, and improve outcomes for HS patients; Whereas Federal policy can play a critical role in improving access to biologic therapies, wound care, and comprehensive care for HS patients; and Whereas designating the first week of June as ``Hidradenitis Suppurativa Awareness Week'' would increase public awareness, foster understanding, and catalyze progress in diagnosing, treating, and ultimately curing HS: Now, therefore, be it Resolved, That the House of Representatives-- (1) supports the designation of ``Hidradenitis Suppurativa Awareness Week''; and (2) recognizes the importance of-- (A) increasing awareness and education about HS among the public and health professionals; (B) promoting timely and accurate diagnosis of HS through improved screening and culturally competent care; (C) supporting biomedical research to better understand HS pathogenesis, treatment efficacy, and long-term outcomes; (D) accelerating the development of effective treatments and expanding access to existing therapies for HS; and (E) advancing policies that improve access to care and quality of life for people living with HS and their caregivers. <all>

• HR8965To promote the economic security and safety of survivors of domestic violence, dating violence, sexual assault, or stalking, and for other purposes.
  Referred to Committee · 2026-05-21
• HR8889National Dam and Hydropower Safety Improvements Act of 2026
  Referred to Committee · 2026-05-19
• HRES1294Supporting the designation of May 15, 2026, as "Endangered Species Day".
  Referred to Committee · 2026-05-15
• HRES1295Expressing support for the designation of May 17, 2026, as "DIPG Awareness Day" to raise awareness and encourage research into cures for diffuse intrinsic pontine glioma (DIPG) and pediatric cancers in general.
  Referred to Committee · 2026-05-15